Type IB variation for application COFEPRIS-2021-0014. Type IB variation: New Dosage Strength for Glucovantib — major revision

Variation Number
COFEPRIS-2021-0014-V014
Type
Type IB
Status
Completed
Fee
€4,333
Submitted
2023-11-24
Approved
—
Description

Type IB variation: New Dosage Strength for Glucovantib — major revision